Evidence map›Paper›PMID 40843680›Full record

ArticleAntibodies (Basel, Switzerland)2025

A 3D Surface Plot for the Effective Visualization of Specific Serum Antibody Binding Properties.

József Prechl, Ágnes Kovács, Krisztián Papp, Zoltán Hérincs, Tamás Pfeil

Abstract read
In one paragraph

Article in Antibodies (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

József PrechlR&D Laboratory, Diagnosticum Zrt, 1047 Budapest, Hungary.ORCID 0000-0003-3859-4353
Ágnes KovácsDepartment of Biostatistics, University of Veterinary Medicine Budapest, 1078 Budapest, Hungary.ORCID 0000-0002-3588-2854
Krisztián PappR&D Laboratory, Diagnosticum Zrt, 1047 Budapest, Hungary.ORCID 0000-0003-0619-8233
Zoltán HérincsR&D Laboratory, Diagnosticum Zrt, 1047 Budapest, Hungary.ORCID 0000-0001-9743-1891
Tamás PfeilDepartment of Applied Analysis and Computational Mathematics, Eötvös Loránd University, 1117 Budapest, Hungary.ORCID 0000-0001-5971-3257

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhen an antigen molecule is exposed to serum, many different kinds of antibodies bind to it. The complexity of these binding events is only poorly characterized by assays that generate a single variable, generally reflecting the fractional saturation of the antigen, as the readout.

methodsWe have previously devised an assay that delivers the essential biochemical variables to determine fractional saturation as the output: an equilibrium dissociation constant for affinity, the ratio of antibody concentration to the equilibrium constant and the concentration of bound antibodies under reference conditions. Here we propose a visualization method for the practical and informative display of these variables.

resultsUsing total antigen concentration and free and bound antibody concentration as coordinates in a three-dimensional space, a surface plot can depict the behavior of serum antibodies in the measurement range and identify the values of the key variables of binding activity. This surface display (antibody binding in 3-concentration display, Ab3cD) was used for the characterization of antibody binding to the SARS-CoV-2 spike protein in seronegative and seropositive sera. We demonstrate that this visualization scheme is suitable for presenting both individual and group differences and that epitope density changes, not commonly measured by immunoassays, are also revealed by the method.

conclusionsWe recommend the use of 3D visualization whenever detailed, informative and characteristic differences in serum antibody reactivity are studied.

Indexed as

antibodyquantitative systems biologyserologyvisualization

Identifiers

PMID40843680
PMCPMC12372043

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.